EUVIMEDEUVIMED entdecken
Crossref

A Novel Noninvasive Approach for Evaluating Suspicious Cervical Lymph Nodes in Papillary Thyroid Carcinoma—Superb Microvascular Imaging

Li-Long Xu, Ling Zhou iD, Xiao-Li Yu, Shi-Yan Li iD

Journal of Clinical Ultrasound · 2025

DOI: 10.1002/jcu.24087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Ultrasound, 2025. Verfasst von Li-Long Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound in Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Thyroid Neoplasms, Lymph Nodes, Microvessels. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the diagnostic performance of superb microvascular imaging (SMI) versus color Doppler flow imaging (CDFI) and fine‐needle aspiration thyroglobulin (FNA‐Tg) in detecting indeterminate cervical lymph nodes (CLNs) in papillary thyroid carcinoma (PTC) patients.

Methods

We prospectively analyzed clinical and imaging data from 74 PTC patients with indeterminate CLNs undergoing FNA biopsy and Tg measurement. Analyses included: (1) univariate comparison of benign versus malignant CLNs; (2) Spearman correlation between imaging features and pathological findings; and (3) receiver operating characteristic curve assessment of diagnostic accuracy.

Results

Among 43 benign and 31 malignant CLNs, significant differences were observed in gender ( p = 0.026), age ( p = 0.041), FNA‐Tg levels ( p < 0.001), and diagnostic outcomes for CDFI ( p = 0.001) and SMI ( p < 0.001). FNA‐Tg ( r = 0.946), SMI ( r = 0.707), and CDFI ( r = 0.403) correlated with pathology (all p < 0.001). FNA‐Tg showed superior accuracy (AUC = 0.977) versus SMI (AUC = 0.856) and CDFI (AUC = 0.704). SMI detected more vessels than CDFI in benign (2.00 vs. 1.00) and malignant nodes (3.00 vs. 2.00) ( p < 0.001), with higher overall counts (2.53 ± 1.47 vs. 1.50 ± 1.13, p < 0.001).

Conclusion

SMI outperformed CDFI in microvascular visualization for indeterminate CLNs in PTC. Although FNA‐Tg remained the most accurate diagnostic method, SMI served as a valuable noninvasive alternative, especially when FNA‐Tg was contraindicated or inaccessible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryThyroid NeoplasmsLymph NodesMicrovesselsUltrasonography, Doppler, ColorHumansFemaleMaleMiddle AgedAdultProspective StudiesNeckLymphatic MetastasisBiopsy, Fine-NeedleAgedSensitivity and SpecificityReproducibility of Results

Stichwörter der Autor:innen

cervical lymph node metastasiscolor Doppler flow imagingdiagnostic accuracyfine‐needle aspiration thyroglobulinsuperb microvascular imaging

Autor:innen und Institutionen

  • Department of Ultrasound in Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Pathology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

ORCID-Profile: Ling Zhou, Shi-Yan Li

Förderung

  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Xu, L. L., Zhou, L., Yu, X. L., & Li, S. Y. (2025). A Novel Noninvasive Approach for Evaluating Suspicious Cervical Lymph Nodes in Papillary Thyroid Carcinoma—Superb Microvascular Imaging. Journal of Clinical Ultrasound. https://doi.org/10.1002/jcu.24087

Vancouver

Xu LL, Zhou L, Yu XL, Li SY. A Novel Noninvasive Approach for Evaluating Suspicious Cervical Lymph Nodes in Papillary Thyroid Carcinoma—Superb Microvascular Imaging. Journal of Clinical Ultrasound. 2025. doi:10.1002/jcu.24087

BibTeX
@article{Xu2025,
  author = {Xu, Li-Long and Zhou, Ling and Yu, Xiao-Li and Li, Shi-Yan},
  title = {A Novel Noninvasive Approach for Evaluating Suspicious Cervical Lymph Nodes in Papillary Thyroid Carcinoma—Superb Microvascular Imaging},
  journal = {Journal of Clinical Ultrasound},
  year = {2025},
  doi = {10.1002/jcu.24087}
}
Kostenlos starten →